– Market Screener Citing Reuters
https://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/US-FDA-declines-to-approve-Regeneron-high-dose-Eylea-44205395/
The U.S. Food and Drug Administration on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals’ blockbuster treatment Eylea, the company said, marking
– Market Screener Citing Reuters
The U.S. Food and Drug Administration on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals’ blockbuster treatment Eylea, the company said, marking a blow in the drugmaker’s plans to defend the eye drug against a fast-gaining rival. (Reporting by Raghav Mahobe and Khushi Mandowara in Bengaluru; Editing by Krishna Chandra Eluri and Maju Samuel)
